Whalegun
Home

NovoCure NVCR paid Tarplin, Downs & Young $80K for lobbying in Q1 2023 · Medicare, Health Issues and 1 more issue

Trade details

Type
Lobbying report
Amount
$80,000
Quarter
Q1 2023
Stock
NovoCure NVCR
Client
Novocure
Reported
23/04/20

Up 0.0% from last quarter

What else happened in NovoCure around then

Filed or reported within 30 days of the trade day · 23/03/01~23/04/30

Novocure's other lobbying reports

  • Novocure

    LobbyingNovoCure

    $60K

    Reported 07/20

  • Novocure

    LobbyingNovoCure

    $20K

    Reported 07/20

  • Novocure

    LobbyingNovoCure

    $80K

    Reported 07/20

  • Novocure

    LobbyingNovoCure

    $160K

    Reported 07/19

  • Novocure

    LobbyingNovoCure

    $40K

    Reported 04/20

NovoCure NVCR paid Tarplin, Downs & Young $80K for lobbying in Q1 2023 · Medicare, Health Issues and 1 more issue | Whalegun